Skip to content

Fortrea Holdings

US · FTRE #2796 by market cap Listed 2023
18.55 -1.60 -7.94%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 16 in the most recent period (2026/Q3).
  • Total institutional ownership rose 3.6 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
110.26% +3.60pp
Institutions
407 +16
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund74.62%
Hedge Fund20.29%
Public Company12.17%
Government Pension Fund1.44%
Individual/Insider1.12%
Insurance Company0.79%
Private Company0.76%

Top holders as of 2026-09-30

BlackRock 17.20% · 16.60M sh
The Goldman Sachs Group, Inc. 8.58% · 8.28M sh
Sessa Capital IM, L.P. 4.76% · 4.59M sh
Vanguard Capital Management, LLC 4.32% · 4.17M sh
Vanguard Portfolio Management, LLC 4.05% · 3.91M sh
FMR 3.94% · 3.80M sh
State Street Global Advisors 3.93% · 3.80M sh
Corvex Management LP 3.10% · 2.99M sh
AQR Capital Management 2.97% · 2.87M sh
Geode Capital Management, LLC 2.68% · 2.55M sh
Charles Schwab Investment Management 2.58% · 2.49M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 24 sells

NameRoleStake
Peter Neupert Chairman of the Board & Lead Independent Director 0.26%
Anshul Thakral Chief Executive Officer 0.21%
Thomas Pike Former Chairperson & CEO 0.17%
Mark Morais COO & President of Clinical Services 0.09%
Jill McConnell Officer 0.08%
Erin Russell Independent Director 0.08%
Edward Pesicka Independent Director 0.05%
Amrit Ray Independent Director 0.05%
David Smith Independent Director 0.04%
A. Sanders Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-10 Jill McConnell Officer Intent to Sell (Form 144) -1,032 $17.14
2026-09-09 Jill McConnell Officer Intent to Sell (Form 144) -1,071 $16.53
2026-09-09 Jason Knoblauch Chief Financial Officer Other Derivative Acquisition +144,434 --
2026-09-08 Jill McConnell Officer Intent to Sell (Form 144) -1,051 $16.85
2026-09-08 Mark Morais COO & President of Clinical Services Derivative Exercise and Sale -3,149 $16.85
2026-09-08 Mark Morais COO & President of Clinical Services Intent to Sell (Form 144) -3,149 $16.85
2026-09-08 Carrie Russell VP of Accounting & Chief Accounting Officer Derivative Exercise and Sale -246 $16.85
2026-09-08 Carrie Russell VP of Accounting & Chief Accounting Officer Intent to Sell (Form 144) -246 $16.85
2026-09-07 Mark Morais COO & President of Clinical Services Derivative Exercise and Retained +4,008 --
2026-09-07 Carrie Russell VP of Accounting & Chief Accounting Officer Derivative Exercise and Retained +604 --
2026-08-18 Jill McConnell Officer Intent to Sell (Form 144) -4,892 $18.19
2026-08-18 Mark Morais COO & President of Clinical Services Derivative Exercise and Sale -4,892 $18.19
2026-08-18 Mark Morais COO & President of Clinical Services Intent to Sell (Form 144) -4,892 $18.19
2026-08-17 Mark Morais COO & President of Clinical Services Derivative Exercise and Retained +6,421 --
2026-08-06 Carrie Russell VP of Accounting & Chief Accounting Officer Initial Statement of Beneficial 0 --
2026-08-05 Anshul Thakral Chief Executive Officer Open Market Disposition -111,857 $18.06–18.17
2026-08-04 Anshul Thakral Chief Executive Officer Derivative Exercise and Sale -99,869 $19.03–19.28
2026-08-04 Anshul Thakral Chief Executive Officer Intent to Sell (Form 144) -99,869 $19.16
2026-08-03 Anshul Thakral Chief Executive Officer Derivative Exercise and Retained +316,797 --
2026-08-02 David Smith Independent Director Other Derivative Acquisition +15,840 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

Fortrea Holdings discussion 0 comments

Add a comment